These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 6120791)

  • 1. The effects of 2,5-dimethoxy-4-methylamphetamine (DOM) on operant behavior: interactions with other neuroactive agents.
    Commissaris RL; Semeyn DR; Moore KE; Rech RH
    Commun Psychopharmacol; 1980; 4(5):393-404. PubMed ID: 6120791
    [No Abstract]   [Full Text] [Related]  

  • 2. 1-(2,3-Methylenedioxyphenyl)-2-aminopropane (2,3-MDA): a preliminary investigation.
    Glennon RA; Young R; Soine W
    Gen Pharmacol; 1984; 15(4):361-2. PubMed ID: 6149169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of 2, 5-dimethoxy-4-methylamphetamine (DOM, STP) on successive sensory discrimination behavior maintained by electrical stimulation of the brain reinforcement in the rat.
    Vincent JH; Lenzer II
    Psychol Rep; 1976 Jun; 38(3 Pt 2):1083-92. PubMed ID: 935303
    [No Abstract]   [Full Text] [Related]  

  • 4. The effects of d-lysergic acid diethylamide (LSD), 2,5-dimethoxy-4-methylamphetamine (DOM) and d-amphetamine on operant responding in control and 6-hydroxydopamine-treated rats.
    Commissaris R; Lyness WH; Cordon JJ; Moore KE; Rech RH
    Pharmacol Biochem Behav; 1980 Nov; 13(5):621-6. PubMed ID: 7443731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereoselective effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM) on schedule-controlled behavior.
    Harris RA; Snell D; Loh HH
    Pharmacol Biochem Behav; 1977 Oct; 7(4):307-10. PubMed ID: 928488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral and neuropharmacological analysis of amphetamine and 2,5-dimethoxy-4-methylamphetamine in rats.
    Tilson HA; Baker TG; Chamberlain JH
    Psychopharmacologia; 1975 Nov; 44(3):229-39. PubMed ID: 1208759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of the behavioral effects of 2,5-dimethoxy-4-methyl-amphetamine (DOM) by pretreatment with p-chlorophenylalanine.
    Commissaris RL; Lyness WH; Moore KE; Rech RH
    Pharmacol Biochem Behav; 1980 Oct; 13(4):605-8. PubMed ID: 6449015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential antagonism by metergoline of the behavioral effects of indolealkylamine and phenethylamine hallucinogens in the rat.
    Commissaris RL; Lyness WH; Moore KE; Rech RH
    J Pharmacol Exp Ther; 1981 Oct; 219(1):170-4. PubMed ID: 6793709
    [No Abstract]   [Full Text] [Related]  

  • 9. DOM-stimulus generalization to LSD and other hallucinogenic indolealkylamines.
    Glennon RA; Young R; Jacyno JM; Slusher M; Rosecrans JA
    Eur J Pharmacol; 1983 Jan; 86(3-4):453-9. PubMed ID: 6572591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerance to d-amphetamine and lack of cross-tolerance to other drugs in rats under a multiple schedule of food presentation.
    Brocco MJ; McMillan DE
    J Pharmacol Exp Ther; 1983 Jan; 224(1):34-9. PubMed ID: 6848748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioral interactions of opioid agonists and antagonists with serotonergic systems.
    Rech RH; Mokler DJ; Commissaris RL; Henck JW
    NIDA Res Monogr; 1984 Mar; 49():179-84. PubMed ID: 6434957
    [No Abstract]   [Full Text] [Related]  

  • 12. The effects of 2,5-dimethoxy-4-methylamphetamine (DOM), 2,5-dimethoxy-4-ethylamphetamine (DOET), d-amphetamine, and cocaine in rats trained with mescaline as a discriminative stimulus.
    Winter JC
    Psychopharmacologia; 1975 Oct; 44(1):29-32. PubMed ID: 1197576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The discriminative stimulus properties of 2,5-dimethoxy-4-methylamphetamine (DOM): differentiation from amphetamine.
    Silverman PB; Ho BT
    Psychopharmacology (Berl); 1980; 68(3):209-15. PubMed ID: 6771804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereochemical considerations of the actions of some psychotropic drugs.
    Smith DF
    Pharmacopsychiatry; 1985 May; 18(3):225-30. PubMed ID: 2861608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Congeners of DOM: effect of distribution of the evaluation of pharmacologic data.
    Barfknecht CF; Caputo JF; Tobin MB; Dyer DC; Standirdge RT; Howell HG; Goodwin WR; Partyka RA; Gylys JA; Cavanagh RL
    NIDA Res Monogr; 1978; (22):16-26. PubMed ID: 101880
    [No Abstract]   [Full Text] [Related]  

  • 16. A comparison of the discriminative stimulus properties of R-2,5-dimethoxy-4-methylamphetamine (R-DOM) and S-amphetamine in the rat.
    Tilson HA; Baker TG; Gylys JA
    Psychopharmacologia; 1975 Nov; 44(3):225-8. PubMed ID: 1208758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of psychotomimetics and psychomotor stimulants on two schedules promoting response switching in the rat.
    Evenden J
    Psychopharmacology (Berl); 2002 Oct; 163(3-4):381-90. PubMed ID: 12373438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of intracranial administration of hallucinogens on operant behavior in the rat. II. 2,5-Dimethoxy-4-methylamphetamine (DOM).
    Mokler DJ; Stoudt KW; Sherman LC; Rech RH
    Pharmacol Biochem Behav; 1987 Nov; 28(3):327-34. PubMed ID: 3685066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of d-lysergic acid diethylamide, d-2-bromolysergic acid diethylamide, dl-2,5-dimethoxy-4-methylamphetamine and d-amphetamine on classical conditioning of the rabbit nictitating membrane response.
    Harvey JA; Gormezano I; Cool VA
    J Pharmacol Exp Ther; 1982 May; 221(2):289-94. PubMed ID: 6122729
    [No Abstract]   [Full Text] [Related]  

  • 20. Interactions of metergoline with diazepam, quipazine, and hallucinogenic drugs on a conflict behavior in the rat.
    Commissaris RL; Rech RH
    Psychopharmacology (Berl); 1982; 76(3):282-5. PubMed ID: 6808551
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.